Literature DB >> 16569850

Contribution of rpoB2 RNA polymerase beta subunit gene to rifampin resistance in Nocardia species.

Jun Ishikawa1, Kazuhiro Chiba, Haruyo Kurita, Hiroyuki Satoh.   

Abstract

Nocardia species are gram-positive environmental saprophytes, but some cause the infectious disease nocardiosis. The complete genomic sequence of Nocardia farcinica IFM 10152 has been determined, and analyses indicated the presence of two different RNA polymerase beta subunit genes, rpoB and rpoB2, in the genome (J. Ishikawa, A. Yamashita, Y. Mikami, Y. Hoshino, H. Kurita, K. Hotta, T. Shiba, and M. Hattori, Proc. Natl. Acad. Sci. USA 101:14925-14930, 2004). These genes share 88.8% identity at the nucleotide level. Moreover, comparison of their amino acid sequences with those of other bacterial RpoB proteins suggested that the nocardial RpoB protein is likely to be rifampin (RIF) sensitive, whereas RpoB2 protein contains substitutions at the RIF-binding region that are likely to confer RIF resistance. Southern analysis indicated that rpoB duplication is widespread in Nocardia species and is correlated with the RIF-resistant phenotype. The introduction of rpoB2 by using a newly developed Nocardia-Escherichia coli shuttle plasmid vector and transformation system conferred RIF resistance to Nocardia asteroides IFM 0319T, which has neither RIF resistance nor rpoB duplication. Furthermore, unmarked rpoB2 deletion mutants of N. farcinica IFM 10152 showed no significant resistance to RIF. These results indicated the contribution of rpoB2 to RIF resistance in Nocardia species. Since this is the first example of genetic engineering of the Nocardia genome, we believe that this study, as well as our determination of the N. farcinica genome sequence, will be a landmark in Nocardia genetics.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16569850      PMCID: PMC1426977          DOI: 10.1128/AAC.50.4.1342-1346.2006

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  The complete genomic sequence of Nocardia farcinica IFM 10152.

Authors:  Jun Ishikawa; Atsushi Yamashita; Yuzuru Mikami; Yasutaka Hoshino; Haruyo Kurita; Kunimoto Hotta; Tadayoshi Shiba; Masahira Hattori
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-04       Impact factor: 11.205

2.  Nucleotide sequences encoding and promoting expression of three antibiotic resistance genes indigenous to Streptomyces.

Authors:  M J Bibb; M J Bibb; J M Ward; S N Cohen
Journal:  Mol Gen Genet       Date:  1985

3.  Compensatory evolution in rifampin-resistant Escherichia coli.

Authors:  M G Reynolds
Journal:  Genetics       Date:  2000-12       Impact factor: 4.562

4.  Insertional mutagenesis and illegitimate recombination in mycobacteria.

Authors:  G V Kalpana; B R Bloom; W R Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

5.  Distribution of nocardia species in clinical samples and their routine rapid identification in the laboratory.

Authors:  Georges Wauters; Véronique Avesani; Jacqueline Charlier; Michèle Janssens; Mario Vaneechoutte; Michel Delmée
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

6.  Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis.

Authors:  S B Snapper; R E Melton; S Mustafa; T Kieser; W R Jacobs
Journal:  Mol Microbiol       Date:  1990-11       Impact factor: 3.501

7.  Lysogeny and transformation in mycobacteria: stable expression of foreign genes.

Authors:  S B Snapper; L Lugosi; A Jekkel; R E Melton; T Kieser; B R Bloom; W R Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

8.  Nocardial infections in Japan from 1992 to 2001, including the first report of infection by Nocardia transvalensis.

Authors:  A Kageyama; K Yazawa; J Ishikawa; K Hotta; K Nishimura; Y Mikami
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

9.  RNA polymerase mutation activates the production of a dormant antibiotic 3,3'-neotrehalosadiamine via an autoinduction mechanism in Bacillus subtilis.

Authors:  Takashi Inaoka; Kosaku Takahashi; Hiroshi Yada; Mitsuru Yoshida; Kozo Ochi
Journal:  J Biol Chem       Date:  2003-11-11       Impact factor: 5.157

10.  Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis.

Authors:  Deneke H Mariam; Yohannes Mengistu; Sven E Hoffner; Dan I Andersson
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

View more
  19 in total

1.  Identification of nocobactin NA biosynthetic gene clusters in Nocardia farcinica.

Authors:  Yasutaka Hoshino; Kazuhiro Chiba; Keiko Ishino; Toshio Fukai; Yasuhiro Igarashi; Katsukiyo Yazawa; Yuzuru Mikami; Jun Ishikawa
Journal:  J Bacteriol       Date:  2010-11-19       Impact factor: 3.490

2.  Involvement of the beta subunit of RNA polymerase in resistance to streptolydigin and streptovaricin in the producer organisms Streptomyces lydicus and Streptomyces spectabilis.

Authors:  Marina Sánchez-Hidalgo; Luz Elena Núñez; Carmen Méndez; José A Salas
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

3.  Activation of dormant bacterial genes by Nonomuraea sp. strain ATCC 39727 mutant-type RNA polymerase.

Authors:  Adelfia Talà; Guojun Wang; Martina Zemanova; Susumu Okamoto; Kozo Ochi; Pietro Alifano
Journal:  J Bacteriol       Date:  2008-12-01       Impact factor: 3.490

Review 4.  Strain improvement in actinomycetes in the postgenomic era.

Authors:  Richard H Baltz
Journal:  J Ind Microbiol Biotechnol       Date:  2011-01-21       Impact factor: 3.346

5.  Characterization of a rifampin-inactivating glycosyltransferase from a screen of environmental actinomycetes.

Authors:  Peter Spanogiannopoulos; Maulik Thaker; Kalinka Koteva; Nicholas Waglechner; Gerard D Wright
Journal:  Antimicrob Agents Chemother       Date:  2012-07-16       Impact factor: 5.191

6.  The Structure of the Antibiotic Deactivating, N-hydroxylating Rifampicin Monooxygenase.

Authors:  Li-Kai Liu; Heba Abdelwahab; Julia S Martin Del Campo; Ritcha Mehra-Chaudhary; Pablo Sobrado; John J Tanner
Journal:  J Biol Chem       Date:  2016-08-24       Impact factor: 5.157

7.  Homozygous triplicate mutations in three 16S rRNA genes responsible for high-level aminoglycoside resistance in Nocardia farcinica clinical isolates from a Canada-wide bovine mastitis epizootic.

Authors:  Takahisa Kogure; Reona Shimada; Jun Ishikawa; Katsukiyo Yazawa; June M Brown; Yuzuru Mikami; Tohru Gonoi
Journal:  Antimicrob Agents Chemother       Date:  2010-03-22       Impact factor: 5.191

Review 8.  Engineering microbial hosts for production of bacterial natural products.

Authors:  Mingzi M Zhang; Yajie Wang; Ee Lui Ang; Huimin Zhao
Journal:  Nat Prod Rep       Date:  2016-04-13       Impact factor: 13.423

Review 9.  The impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin?

Authors:  Anastasia Koch; Valerie Mizrahi; Digby F Warner
Journal:  Emerg Microbes Infect       Date:  2014-03-12       Impact factor: 7.163

10.  Comprehensive genome analyses of Sellimonas intestinalis, a potential biomarker of homeostasis gut recovery.

Authors:  Marina Muñoz; Enzo Guerrero-Araya; Catalina Cortés-Tapia; Angela Plaza-Garrido; Trevor D Lawley; Daniel Paredes-Sabja
Journal:  Microb Genom       Date:  2020-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.